Your browser doesn't support javascript.
loading
Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.
Cocconi, G; Bisagni, G; Bella, M; Acito, L; Anastasi, P; Carpi, A; Di Costanzo, F; Frassoldati, A; Mosconi, A; Borrini, A; Buzzi, P.
Affiliation
  • Cocconi G; Medical Oncology Institutions of Parma, Italy.
Am J Clin Oncol ; 22(6): 593-600, 1999 Dec.
Article in En | MEDLINE | ID: mdl-10597744
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Methotrexate / Antineoplastic Agents, Alkylating / Cyclophosphamide / Fluorouracil / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Am J Clin Oncol Year: 1999 Document type: Article Affiliation country: Italia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Methotrexate / Antineoplastic Agents, Alkylating / Cyclophosphamide / Fluorouracil / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Am J Clin Oncol Year: 1999 Document type: Article Affiliation country: Italia